Use of PIC/S Inspection Outcomes in Regulatory Submissions
Use of PIC/S Inspection Outcomes in Regulatory Submissions Leveraging PIC/S Inspection Outcomes in Regulatory Submissions In today’s globally harmonized pharmaceutical landscape, regulatory submissions require more than just clinical data—they demand verifiable proof of Good Manufacturing Practice (GMP) compliance. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) plays a central role in this ecosystem by offering harmonized GMP…
Read More “Use of PIC/S Inspection Outcomes in Regulatory Submissions” »